← Leaderboards
Kevin Foxman Boehnke
University Of Michigan At Ann Arbor
$1,899,756
Attributed
$4,423,277
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,423,277 · 3
By mechanism
U01$3,579,362 · 1
K01$569,355 · 1
R34$274,560 · 1
Top collaborators
- Joel Joseph Gagnier5 shared
- Chad M Brummett3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Joel Joseph Gagnier$1,538,976
- Richard E Harris$13,043,112
- Steven Edward Harte$6,619,782
- John R Traynor$25,558,598
- Natalia Harris$136,935
Others in their field
Other Emerging Leaders on “Sleep”
- Chanza Baytop · Westat, Inc.$271,217,917
- Andrew S Huhn · Johns Hopkins University$19,514,484
- Patricia Shifflett · Westat, Inc.$16,650,520
- Ashok Kumar Krishnamurthy · Univ Of North Carolina Chapel Hill$15,371,772
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,230,366
- Michael P Harms · Washington University$13,645,932
Research focus
SleepRandomizedPain ManagementSide EffectOpioidPlacebosPainClinical TrialsPain ReductionParticipantDesignOperative Surgical ProceduresPharmaceutical PreparationsAnti-Inflammatory AgentsChronic PainDouble-Blind MethodAffectChronicAmericanKnee OsteoarthritisAnalgesicsCannabidiolCannabinoidsTetrahydrocannabinol
Grant awards (9)
Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty â a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)$1,109,271
U01 · FY2025 · AR
Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty â a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)$1,194,710
U01 · FY2024 · AR
Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty â a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)$1,275,381
U01 · FY2023 · AR
Cannabinoid Effects on Sleep and Pain Mechanisms in Osteoarthritis of the Knee$142,475
K01 · FY2023 · DA · contact PI
Cannabinoid Effects on Sleep and Pain Mechanisms in Osteoarthritis of the Knee$142,475
K01 · FY2022 · DA · contact PI
Planning Grant for a Clinical Trial Of Cannabidiol For Postoperative Opioid Reduction in Primary Total Knee Arthroplasty$68,640
R34 · FY2022 · AR · contact PI
Planning Grant for a Clinical Trial Of Cannabidiol For Postoperative Opioid Reduction in Primary Total Knee Arthroplasty$205,920
R34 · FY2021 · AR · contact PI
Cannabinoid Effects on Sleep and Pain Mechanisms in Osteoarthritis of the Knee$142,328
K01 · FY2021 · DA · contact PI
Cannabinoid Effects on Sleep and Pain Mechanisms in Osteoarthritis of the Knee$142,077
K01 · FY2020 · DA · contact PI